[1] 中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会,倪青.糖尿病高血压病证结合诊疗指南[J].环球中医药,2024,17(1):173-187. [2] Jia G, Sowers J R.Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease[J]. Hypertension, 2021, 78(5): 1197-1205. [3] Usui I.Common metabolic features of hypertension and type 2 diabetes[J]. Hypertens Res, 2023, 46(5): 1227-1233. [4] Favre G A, Esnault V L, Van Obberghen E.Modulation of glucose metabolism by the renin-angiotensin-aldosterone system[J]. Am J Physiol Endocrinol Metab, 2015, 308(6): E435-449. [5] Lastra-Lastra G, Sowers J R, Restrepo-Erazo K, et al.Role of aldosterone and angiotensin II in insulin resistance: an update[J]. Clin Endocrinol (Oxf), 2009, 71(1): 1-6. [6] Schulman I H, Zhou M S.Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases[J]. Curr Hypertens Rep, 2009, 11(1): 48-55. [7] 程国美,段慧卿,高玲,等.“健康信念”教育模式对增强门诊高血压患者健康促进生活方式的影响[J].中国实用护理杂志,2014,30(1):156. [8] 中华医学会,中华医学会临床药学分会,中华医学会杂志社,等.高血压基层合理用药指南[J].中华全科医师杂志,2021,20(1):21-28. [9] 中国医师协会检验医师分会慢病管理检验医学专家委员会.糖尿病的实验室诊断管理专家共识[J].临床检验杂志,2020,38(7):481-487. [10] 中华预防医学会糖尿病预防与控制专业委员会.中国糖尿病行为与生活方式干预指南(2024版)[J].中国全科医学,2025,28(7):777-796. [11] Hashemi R, Rabizadeh S, Yadegar A, et al.High prevalence of comorbidities in older adult patients with type 2 diabetes: a cross-sectional survey[J]. BMC Geriatr, 2024, 24(1): 873. [12] Liu R, Dahlan A, Teng N I M F, et al. Barriers to Health Self-Management Among Older People with Hypertension and Diabetes in Institutions in China: A Phenomenological Study[J]. Environment-Behaviour Proceedings Journal, 2024, 9(27): 137-142. [13] Chantzaras A, Yfantopoulos J.Determinants of medication adherence in patients with diabetes, hypertension, and hyperlipidemia[J]. Hormones (Athens), 2025, 24(2): 443-459. |